Protection and preservation of product quality

JPAC Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee

Welcome
Latest Updates
Publication Information
Figures
Tables
Preface
Change Notifications
Contents
1: Introduction
2: Quality in blood and tissue establishments and hospital blood banks
3: Care and selection of whole blood and component donors (including donors of pre-deposit autologous blood)
4: Premises and quality assurance at blood donor sessions
- 4.1: Premises
- 4.2: Staffing and training principles for donation sessions
- 4.3: Collection of the donation
- 4.4: Donor identification
- 4.5: Labelling
- 4.6: Records
- 4.7: Control of purchased material and services
- 4.8: Protection and preservation of product quality
- 4.9: References
5: Collection of a blood or component donation
6: Evaluation and manufacture of blood components
7: Specifications for blood components
8: Evaluation of novel blood components, production processes and blood packs: generic protocols
9: Microbiology tests for donors and donations: general specifications for laboratory test procedures
10: Investigation of suspected transfusion-transmitted infection
11: Reagent manufacture
12: Donation testing (red cell immunohaematology)
13: Patient testing (red cell immunohaematology)
14: Guidelines for the use of DNA/PCR techniques in Blood Establishments
15: Molecular typing for red cell antigens
16: HLA typing and HLA serology
17: Granulocyte immunology
18: Platelet immunology
19: Tissue banking: general principles
20: Tissue banking: selection of donors
21: Tissue banking: tissue retrieval and processing
22: Haemopoietic progenitor cells
23: Specification for the uniform labelling of blood, blood components and blood donor samples
24: Specification for the uniform labelling of human tissue products using ISBT 128
25: Standards for electronic data interchange within the UK Blood Transfusion Services
26: Specification for blood pack base labels
27: Specification for labelling consumables used in therapeutic product production
Annex 1: Standards available from the National Institute for Biological Standards and Control
Annex 2: ISBT 128 check character calculation
Annex 3 -Trial Components
Definitions
Abbreviations

4.8: Protection and preservation of product quality

All whole blood and apheresis components must be transported, tested and stored in accordance with the specifications for blood components in Chapters 7 and 8.